Skip to main content

Table 2 Serum 25(OH)D concentrations in the control group by polymorphisms in the vitamin D receptor gene

From: Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk

Polymorphism

Genotype

  

P a

TaqI

TT: 49.8 (32.6–67.5)

Tt: 47.1 (32.5–66.1)

tt: 48.1 (32.7–69.8)

0.52

FokI

FF: 49.2 (33.0–66.9)

Ff: 48.2 (32.4–67.4)

ff: 47.9 (31.7–69.7)

0.85

VDR-5132

CC: 49.1 (32.9–66.9)

CT: 48.6 (32.6–68.3)

TT: 47.7 (31.6–66.9)

0.78

Cdx2

GG: 48.5 (32.5–67.4)

GA: 48.7 (31.9–66.2)

AA: 50.7 (35.0–68.6)

0.56

  1. Values are expressed as median serum 25-hydroxyvitamin D (25 [OH]D; 25th to 75th percentile) in nmol/l. aWilcoxon rank-sum test for median differences by genotype.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us